Davis, T.B.; Gupta, S.; Yang, M.; Pflieger, L.; Rajan, M.; Wang, H.; Thota, R.; Yeatman, T.J.; Pledger, W.J.
Ras Pathway Activation and MEKi Resistance Scores Predict the Efficiency of MEKi and SRCi Combination to Induce Apoptosis in Colorectal Cancer. Cancers 2022, 14, 1451.
https://doi.org/10.3390/cancers14061451
AMA Style
Davis TB, Gupta S, Yang M, Pflieger L, Rajan M, Wang H, Thota R, Yeatman TJ, Pledger WJ.
Ras Pathway Activation and MEKi Resistance Scores Predict the Efficiency of MEKi and SRCi Combination to Induce Apoptosis in Colorectal Cancer. Cancers. 2022; 14(6):1451.
https://doi.org/10.3390/cancers14061451
Chicago/Turabian Style
Davis, Thomas Benjamin, Shilpa Gupta, Mingli Yang, Lance Pflieger, Malini Rajan, Heiman Wang, Ramya Thota, Timothy J. Yeatman, and Warren Jackson Pledger.
2022. "Ras Pathway Activation and MEKi Resistance Scores Predict the Efficiency of MEKi and SRCi Combination to Induce Apoptosis in Colorectal Cancer" Cancers 14, no. 6: 1451.
https://doi.org/10.3390/cancers14061451
APA Style
Davis, T. B., Gupta, S., Yang, M., Pflieger, L., Rajan, M., Wang, H., Thota, R., Yeatman, T. J., & Pledger, W. J.
(2022). Ras Pathway Activation and MEKi Resistance Scores Predict the Efficiency of MEKi and SRCi Combination to Induce Apoptosis in Colorectal Cancer. Cancers, 14(6), 1451.
https://doi.org/10.3390/cancers14061451